Severity of depressive symptoms: the depression subscale of the DASS.15 The depression subscale does not include somatic items, and is therefore less likely to be artificially inflated in a chronic pain setting.
Our finding that
the severity of depressive symptoms in our sample of patients with chronic pain was best correlated with a combination of heightened catastrophising, reduced sense of control over life, increased physical disability, lower pain self - efficacy beliefs, higher use of unhelpful self - management strategies, and lower perceived social support (after controlling for the possible effects of age, sex and duration of pain) is consistent with previous studies of patients with chronic pain.26 Interestingly, and somewhat contrary to clinical expectations, pain severity, pain - related distress, and fear of movement / (re) injury were not significantly associated with depressive symptom severity.
Our finding that
the severity of depressive symptoms was a significant but relatively smaller contributor to physical disability in this sample (after controlling for the possible effects of age, sex and duration of pain) is consistent with findings of some previous studies of patients with chronic pain, but not with some treatment studies, which found that depression level contributed to less significant improvement in pain - related disability.11, 27 It is not surprising that cognitive, pain and behavioural variables accounted for more physical disability than depressive symptoms but it is notable that social support (as measured by the MPI), sense of control over life, and catastrophising did not significantly contribute to physical disability.
Beck Depression Inventory (BDI): It was developed in order to assess the risk of depression and the level and
severity of depressive symptoms [14].
The questions measured the quantitative aspects of depression and
the severity of depressive symptoms regarding the most common characteristics of patients with depression observed in clinical practice (M.K.).
Both latent variable models supported the internal construct validity of a single underlying continuum of
severity of depressive symptoms.
In patients with angiographically - documented coronary artery disease and co-morbid depression, dietary supplementation with EPA - rich fish oil over six months will influence
the severity of depressive symptoms.
A ten - item diagnostic questionnaire used with patients with mood disorders to measure
severity of depressive episodes.
The RADS - 2 (30 items) is a self - report measure used to assess the current
severity of depressive symptoms in adolescents of ages 11 — 20 years.
The mother's initial diagnosis was established by clinical interview and confirmed using a symptom checklist based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM - IV).13
The severity of depressive symptoms was estimated using the HRSD.15, 16 Maternal remission was defined as an HRSD score of 7 or less, and response was defined as a 50 % or greater reduction of the baseline HRSD score.
The Hamilton Rating Scale for Depression — 17 - Item42 was used to evaluate
the severity of depressive symptoms.
Included studies used several tools for measuring
the severity of depressive symptoms, namely the Hamilton Depression Rating Scale (HAM - D), 21 22 30 34 35 Patient Health Questionnaire - 9 (PHQ - 9), 24 36 Geriatric Depression Scale (GDS), 23 26 28 Hopkins Symptom Checklist - 20 (HSCL - 20), 37 38 Montgomery - Asberg Depression Rating Scale (MADRS), 18 25 27 Beck Depression Inventory - Fast Screen (BDI - FS) 39 and Center of Epidemiologic Studies Depression Scale (CES - D).40 These tools have different score ranges (HAM - D = 0 — 53, PHQ - 9 = 0 — 27, GDS = 0 — 15, HSCL - 20 = 0 — 4, MADRS = 0 — 60, BDI - FS = 0 — 21 and CES - D = 0 — 60), with higher scores in all tools representing increasing severity of depressive symptoms.
At both baseline and follow - up there was a high rate of depressive symptoms with one third of the group scoring 14 or more on the Beck Depression Inventory (a questionnaire designed to measure
severity of depressive symptoms).
One study found that ACT significantly decreased
the severity of depressive symptoms for veterans with depression and suicidal thoughts (Walser, Garvert, Karlin, Trockel, Ryu, & Taylor, 2015).
In addition, the study found that impairments in executive functioning and language ability in particular predicted
the severity of depressive symptoms after 12 months.
Bariatric surgery was, however, consistently associated with postoperative decreases in the prevalence of depression (7 studies; 8 percent - 74 percent decrease) and
the severity of depressive symptoms (6 studies; 40 percent - 70 percent decrease).
Not exact matches
By contrast, patient age,
severity of illness, ICU or hospital length
of stay, and duration
of sedation were not associated with
depressive symptoms.
The
severity and duration
of the sad feelings, as well as the presence
of other symptoms, are factors that distinguish ordinary sadness from a
depressive disorder.
First, the duration
of the current maternal
depressive episode, but not the
severity of this episode, was associated with the CBCL scores at baseline.
Given that children are not yet through the period
of risk for the development
of major depression and that so few children in the comparison group met diagnostic criteria for any
depressive disorder, the dimensional
severity measure derived from the Mood and Feelings Questionnaire was used in subsequent analyses examining predictors
of depression in the children.
Paternal MDD was also significantly associated with MDD in offspring, but only among offspring with
depressive episodes
of moderate or greater
severity.
After controlling for the child's age and sex and adjusting for baseline
severity of child and maternal symptoms, there was a significantly larger decrease in internalizing (adjusted mean score difference, 8.6; P <.001), externalizing (6.6; P =.004), and total (8.7; P <.001) symptoms among children
of mothers who had a remission from major
depressive disorder over the 3 - month period than among children
of mothers whose major
depressive disorder did not remit (Table 4).
In the future, it will be important to obtain longitudinal assessments and examine the predictive power
of measures
of social supports in determining
severity and persistence
of depressive symptomatology over time.
CONCLUSION: In addition to making criteria - based diagnoses
of depressive disorders, the PHQ - 9 is also a reliable and valid measure
of depression
severity.
Secondary outcomes were patient cognitive function,
depressive symptoms, psychiatric symptoms and behavioural disturbances, and overall
severity of dementia.
One
of the oldest and most frequently used screening questionnaires to measure the
severity of and change in
depressive symptoms among adults in an inpatient setting.
While affective symptom
severity levels are anchored to the diagnostic thresholds for all
depressive and manic conditions, including MDE, minor
depressive / dysthymic disorder, mania, and hypomania, weekly levels were assigned regardless
of whether the patient was in an RDC - defined episode.
AAI, Adult Attachment Interview; AFFEX, System for Identifying Affect Expression by Holistic Judgement; AIM, Affect Intensity Measure; AMBIANCE, Atypical Maternal Behaviour Instrument for Assessment and Classification; ASCT, Attachment Story Completion Task; BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; BEST, Borderline Evaluation
of Severity over Time; BPD, borderline personality disorder; BPVS - II, British Picture Vocabulary Scale II; CASQ, Children's Attributional Style Questionnaire; CBCL, Child Behaviour Checklist; CDAS - R, Children's Dysfunctional Attitudes Scale - Revised; CDEQ, Children's
Depressive Experiences Questionnaire; CDIB, Child Diagnostic Interview for Borderlines; CGAS, Child Global Assessment Schedule; CRSQ, Children's Response Style Questionnaire; CTQ, Childhood Trauma Questionnaire; CTQ, Childhood Trauma Questionnaire; DASS, Depression, Anxiety, Stress Scales; DERS, Difficulties in Emotion Regulation Scale; DIB - R, Revised Diagnostic Interview for Borderlines; DSM, Diagnostic and Statistical Manual of Mental Disorders; EA, Emotional Availability Scales; ECRS, Experiences in Close Relationships Scale; EMBU, Swedish acronym for Own Memories Concerning Upbringing; EPDS, Edinburgh Postnatal Depression Scale; FES, Family Environment Scale; FSS, Family Satisfaction Scale; FTRI, Family Trauma and Resilience Interview; IBQ - R, Infant Behaviour Questionnaire, Revised; IPPA, Inventory of Parent and Peer Attachment; K - SADS, Kiddie Schedule for Affective Disorders and Schizophrenia for School - Age Children; KSADS - E, Kiddie Schedule for Affective Disorders and Schizophrenia - Episodic Version; MMD, major depressive disorder; PACOTIS, Parental Cognitions and Conduct Toward the Infant Scale; PPQ, Perceived Parenting Quality Questionnaire; PD, personality disorder; PPVT - III, Peabody Picture Vocabulary Test, Third Edition; PSI - SF, Parenting Stress Index Short Form; RSSC, Reassurance - Seeking Scale for Children; SCID - II, Structured Clinical Interview for DSM - IV; SCL -90-R, Symptom Checklist 90 Revised; SCQ, Social Communication Questionnaire; SEQ, Children's Self - Esteem Questionnaire; SIDP - IV, Structured Interview for DSM - IV Personality; SPPA, Self - Perception Profile for Adolescents; SSAGA, Semi-Structured Assessment for the Genetics of Alcoholism; TCI, Temperament and Character Inventory; YCS, Youth Chronic Stress Interview; YSR, Youth Self
Depressive Experiences Questionnaire; CDIB, Child Diagnostic Interview for Borderlines; CGAS, Child Global Assessment Schedule; CRSQ, Children's Response Style Questionnaire; CTQ, Childhood Trauma Questionnaire; CTQ, Childhood Trauma Questionnaire; DASS, Depression, Anxiety, Stress Scales; DERS, Difficulties in Emotion Regulation Scale; DIB - R, Revised Diagnostic Interview for Borderlines; DSM, Diagnostic and Statistical Manual
of Mental Disorders; EA, Emotional Availability Scales; ECRS, Experiences in Close Relationships Scale; EMBU, Swedish acronym for Own Memories Concerning Upbringing; EPDS, Edinburgh Postnatal Depression Scale; FES, Family Environment Scale; FSS, Family Satisfaction Scale; FTRI, Family Trauma and Resilience Interview; IBQ - R, Infant Behaviour Questionnaire, Revised; IPPA, Inventory
of Parent and Peer Attachment; K - SADS, Kiddie Schedule for Affective Disorders and Schizophrenia for School - Age Children; KSADS - E, Kiddie Schedule for Affective Disorders and Schizophrenia - Episodic Version; MMD, major
depressive disorder; PACOTIS, Parental Cognitions and Conduct Toward the Infant Scale; PPQ, Perceived Parenting Quality Questionnaire; PD, personality disorder; PPVT - III, Peabody Picture Vocabulary Test, Third Edition; PSI - SF, Parenting Stress Index Short Form; RSSC, Reassurance - Seeking Scale for Children; SCID - II, Structured Clinical Interview for DSM - IV; SCL -90-R, Symptom Checklist 90 Revised; SCQ, Social Communication Questionnaire; SEQ, Children's Self - Esteem Questionnaire; SIDP - IV, Structured Interview for DSM - IV Personality; SPPA, Self - Perception Profile for Adolescents; SSAGA, Semi-Structured Assessment for the Genetics of Alcoholism; TCI, Temperament and Character Inventory; YCS, Youth Chronic Stress Interview; YSR, Youth Self
depressive disorder; PACOTIS, Parental Cognitions and Conduct Toward the Infant Scale; PPQ, Perceived Parenting Quality Questionnaire; PD, personality disorder; PPVT - III, Peabody Picture Vocabulary Test, Third Edition; PSI - SF, Parenting Stress Index Short Form; RSSC, Reassurance - Seeking Scale for Children; SCID - II, Structured Clinical Interview for DSM - IV; SCL -90-R, Symptom Checklist 90 Revised; SCQ, Social Communication Questionnaire; SEQ, Children's Self - Esteem Questionnaire; SIDP - IV, Structured Interview for DSM - IV Personality; SPPA, Self - Perception Profile for Adolescents; SSAGA, Semi-Structured Assessment for the Genetics
of Alcoholism; TCI, Temperament and Character Inventory; YCS, Youth Chronic Stress Interview; YSR, Youth Self - Report.
Subgroup analyses showed significant differences for continent
of residence and depression
severity (ie,
depressive symptoms or a clinical diagnosis depression).
Also
of interest was that preschoolers who had recovered from MDD still had higher MDD
severity scores than controls with psychiatric disorders and no disorders, suggesting that a relatively high number
of residual
depressive symptoms were still manifest even during periods
of recovery.
This model allowed adjustment for prespecified baseline covariates: treatment centre, gender, baseline age, frequency,
severity and risk
of self - harm, psychosocial risk, behavioural disorder and
depressive disorder.
Despite a reduction
of 50 % in
depressive symptom
severity by 16 weeks, there were no significant improvements in neuropsychological functioning in the depressed group once practice effects (benchmarked against the control group) were taken into account.
Of note was that the depressed preschoolers who demonstrated a chronic 24 - month course had the highest MDD severity scores at baseline, which suggests that a more severe depressive episode is a harbinger of greater chronicity in early childhoo
Of note was that the depressed preschoolers who demonstrated a chronic 24 - month course had the highest MDD
severity scores at baseline, which suggests that a more severe
depressive episode is a harbinger
of greater chronicity in early childhoo
of greater chronicity in early childhood.
Results indicate that IPT resulted in significant improvement in
depressive symptoms relative to the WLC based on (1) the absolute reduction in symptom levels as measured by the HRSD and the BDI; (2) the proportion
of women who responded to treatment reduction in symptom
severity as measured by the HRSD and the BDI); (3) the proportion
of women who met HRSD and BDI criteria for recovery; and (4) the proportion
of women who no longer met DSM - IV criteria for major depression.
Presence
of personality disorder was nonsignificantly associated with elevated
depressive severity (Cluster A: 5 points on the Ham - D and BDI; Cluster B: 0 points on the Ham - D, 1 point on the BDI; Cluster C: 3 points on the Ham - D, 1 point on the BDI).
This will reduce the
severity of both manic and
depressive symptoms.
Primary outcomes were the Posttraumatic Diagnostic Scale (PDS) 25,26 for PTSD symptoms and the Symptom Checklist Depression Scale (SCL - 20) for
depressive symptoms.27 The PDS (17 items) assesses
severity of PTSD symptoms over the prior 4 weeks with high internal consistency and test - retest reliability26; scores are summed and range from 0 to 51; scores
of 10 or less are mild; 11 to 20, moderate; 21 to 35, moderate to severe; and at least 36, severe.
Chronicity,
severity, and timing
of maternal
depressive symptoms: relationships with child outcomes at age 5.
This gives a range
of scores from 0 to 56 with higher scores representing higher
depressive symptom
severity.
Absence
of a significant association between physical victimization and
depressive symptom
severity in the current study might be related to the non-severe nature
of victimization (Johnson 1995, 2008).
After adjusting for the duration and
severity of maternal depression, duration
of treatment, number
of depressive episodes after delivery, maternal IQ and socioeconomic status, the study showed that tricyclic antidepressants and fluoxetine had no adverse effects on the global IQ, language development or behaviour
of children between 15 and 71 months
of age [60].
Regression analyses indicated that, above and beyond demographic characteristics, ADHD symptom
severity, and initial levels
of comorbidity, sleep problems significantly predicted greater ODD symptoms, general externalizing behavior problems, and
depressive symptoms 1 year later.
Maternal Depression and Youth Internalizing and Externalizing Symptomatology:
Severity and Chronicity
of Past Maternal Depression and Current Maternal
Depressive Symptoms.
Level
of baseline
depressive symptom
severity did not moderate these relationships.
The association between physical victimization and
depressive symptom
severity in the current sample
of depressed patients was not statistically significant for either men or women.
In the current study, the range
of depressive symptom
severity was restricted to moderate to high levels.
After controlling for these variables, the order in which variables significantly correlated with physical disability (RMDQ scores) were: fear
of movement / (re) injury, pain self - efficacy, pain
severity, use
of unhelpful management strategies and, finally,
depressive symptoms.
The range
of variables entered into both sets
of multiple regression analyses were subscales
of the MPI (pain
severity, life control, support), physical disability (measured by the RMDQ),
depressive symptoms (measured by the DASS), pain self - efficacy (measured by the PSEQ), catastrophising (measured by the PRSS), fear
of movement / (re) injury (measured by the TSK), pain distress in the past week, and use
of unhelpful self - management strategies (measured by the PSMC).
The Pearson's correlation between measures
of prenatal and postnatal EPDS scores was 0.600 (r = 0.600; p < 0.001, df = 201), however the
severity of maternal
depressive symptoms was significantly greater during pregnancy than at early postnatal period (t = 3.587, df = 200, p = 0.000).
These findings remained unchanged even after additionally controlling for the
severity of maternal
depressive symptoms averaged across pregnancy and early postnatal period, monthly household income, and sleep condition during the EEG recording.